Beranda › Limfoma › California › Los Angeles
Uji klinis Limfoma di Los Angeles, CA
10 studi untuk Limfoma mencari peserta di lokasi sekitar Los Angeles (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- University of Southern California, Los Angeles
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Menerima pesertaFase 1/2
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Menerima pesertaFase 2
- Cedars-Sinai Medical Center, Los Angeles
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Menerima pesertaFase 1/2
- Children's Hospital Los Angeles, Los Angeles
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Menerima pesertaFase 3
- Valkyrie Clinical Trials, Los Angeles
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Children s Hospital of Los Angeles, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Menerima pesertaFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Menerima pesertaFase 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Menerima pesertaFase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA), Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Menerima pesertaFase 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Uji klinis Limfoma di kota lain
- Houston, TX34 studi
- Boston, MA33 studi
- New York City, NY33 studi
- Washington, DC23 studi
- Baldwin Park, CA21 studi
- Chicago, IL20 studi
- Durham, NC17 studi
- St. Louis, MO15 studi
- Philadelphia, PA15 studi
- Cleveland, OH14 studi
- Edison, NJ12 studi
- Atlanta, GA12 studi
Studi lain di Los Angeles
- Kanker Paru Non-Sel Kecil87 studi
- Kanker (semua jenis)74 studi
- Kanker Payudara73 studi
- Kanker Prostat61 studi
- Kanker Kolorektal59 studi
- Kanker Metastatik57 studi
- Kanker Ovarium50 studi
- Kanker Paru45 studi
- Karsinoma Sel Skuamosa Kepala dan Leher42 studi
- Kanker Pankreas35 studi
- Kanker Endometrium34 studi
- Melanoma34 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.